Marijuana M&A boom awaits, in California and beyond

Jazz Pharmaceuticals’ $7.2-billion purchase of GW Pharmaceuticals last week is the biggest tie-up yet for the cannabis industry. And it’s probably just the beginning. The blockbuster deal, which dwarfs Tilray Inc. and Aphria Inc.’s $3.8-billion merger as well as Constellation Brands…

Canopy Growth to cut more costs after smaller-than-expected loss

Canopy Growth Corp WEED.TO on Friday reported a smaller-than-expected loss in the third quarter, as the Canadian pot producer kept a tight lid on costs amid growing investor pressure to turn in a profit. U.S.-listed shares of the company rose over 15%…

Cannabis market leader Canopy Growth names Constellation Brands’ CFO as its new CEO

Shares soar 13% as CFO of Canopy’s biggest shareholder takes the helm Canopy Growth Corp. said Monday it has named David Klein, currently chief financial officer at its biggest shareholder, Constellation Brands Inc., as its new chief executive, taking over…

Canopy Growth to Build First U.S. Hemp Plant in New York State

Canopy Growth Corp. will spend as much as $150 million to build its first production facility in the U.S. after the Canadian cannabis company was granted a hemp license by New York state. The U.S. farm bill legalized hemp and…